Home » Archive by Category

News

Original content and news from BioSpace, Xconomy, Marketwire and other sources, specific to the region.

Professor Dennis Burton: In Search of an Effective HIV/AIDS Vaccine

September 15, 2014 – 12:00 am | Edit Post

Developing an HIV vaccine has been the hope for more than 30 years—but the task has turned out to be more complicated than it initially appeared. TSRI Professor Dennis Burton is among those tasked with making an AIDS vaccine a reality.

Donor Eleanor Mosca: Explorer, Caregiver, Educator—and TSRI Supporter

September 15, 2014 – 12:00 am | Edit Post

Eleanor Mosca, a loyal TSRI supporter who has included the institute in her estate plan, says, “I contribute because I feel it’s the building block for improved health and saving lives.”

Graduate Student Sany Hoxha: Captivated by Complexity

September 15, 2014 – 12:00 am | Edit Post

The aspiring cancer biologist decided to apply to TSRI’s graduate program after a summer internship at Scripps Florida.

Viking Therapeutics Inc. Prices Planned IPO

September 14, 2014 – 4:06 pm | Edit Post

San Diego-based Viking Therapeutics Inc., a biotech company developing treatments for diabetes and metabolic disorders, has announced the estimated pricing of its initial public offering at $55 million – 5 million shares at a price range of $10 to $12.

Viking Therapeutics Prices Planned IPO

September 12, 2014 – 3:05 pm | Edit Post

San Diego-based Viking Therapeutics Inc., a biotech company developing treatments for diabetes and metabolic disorders, has announced the estimated pricing of its initial public offering at $55 million – 5 million shares at a price range of $10 to $12.

Executive Q&A: Greg Lucier

September 12, 2014 – 12:52 pm | Edit Post

In a single decade Greg Lucier transformed a small biotech startup, Invitrogen Corp., with 1,500 employees into Life Technologies Corp., an international giant with more than 12,000 employees, 5,000 patents, 50,000 products and nearly $4 billion in sal…

When Funds Flow

September 12, 2014 – 12:45 pm | Edit Post

Venture capital investment in the biotechnology sector of San Diego continues to climb despite the industry’s reputation of being volatile and risky.

In Rats and Men, Nicotine Withdrawal Casts Similar Pall

September 12, 2014 – 8:34 am | Edit Post

In a set of novel experiments involving both humans and rats, researchers at the University of California, San Diego School of Medicine, Florida Atlantic University (FAU), University of Pittsburgh, Washington University and Harvard Medical School report that the brain’s response to reward – its ability to recognize and derive pleasure from natural stimuli such as food, money or sex – is measurably reduced after nicotine withdrawal.

West Coast Biotech Roundup: Gates, Orexigen, Medivation & More

September 12, 2014 – 4:30 am | Edit Post
West Coast Biotech Roundup: Gates, Orexigen, Medivation & More

The West Coast news of the past seven days was dominated by approvals. The FDA was responsible for two of them. In San Diego, Orexigen Therapeutics traveled a long, long road with its weight-loss…

[[Click headline to continue reading.]]

How to Attract Smart People, Smart Ideas, and Smart Money

September 12, 2014 – 3:00 am | Edit Post
How to Attract Smart People, Smart Ideas, and Smart Money

North Carolina entrepreneurs are attracting attention all over the nation—and all over the world—across the tech, life science, and advanced materials sectors. The proof is in the…

[[Click headline to continue reading.]]